1. Pink Sheet

CDER Director Patrizia Cavazzoni Retires; Corrigan-Curay Named Acting Head

 
• By Sue Sutter

Cavazzoni, who led the drugs center four-and-a-half years, decided on her own to retire at this time, sources said. The decision may have been a preemptive move knowing her time as head of CDER would have been limited, or at the very least highly challenging, under the new administration.

Sunset on blue sky
The sun is setting on Patrizia Cavazzoni's time with the US FDA. (Shutterstock)
Key Takeaways
  • CDER Director Patrizia Cavazzoni is retiring from the agency on 18 January.
  • Principal Deputy Center Director Jacqueline Corrigan-Curay will serve as acting CDER director.
  • Cavazzoni’s departure adds to the uncertainty for CDER staff and external stakeholders ahead of the administration change.

Center for Drug Evaluation and Research Director Patrizia Cavazzoni’s retirement deepens a US Food and Drug Administration leadership void that has emerged ahead of President-elect Donald Trump’s inauguration and could herald a much larger

Cavazzoni announced plans to retire in a 10 January all-hands email

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Agency Leadership

More from US FDA